MedPath

Mixed and Match vs One-size-fits-all

Not Applicable
Conditions
Smoking Cessation
Interventions
Behavioral: Mixed and match Intervention
Other: Control
Registration Number
NCT05297370
Lead Sponsor
The Hong Kong Polytechnic University
Brief Summary

Most existing smoking cessation services are based on '5A's' and '5R's' models which are recognized by the World Health Organization as a standardized tool for smoking cessation. While there are more techniques that are known to be effective and could be incorporated in existing smoking cessation interventions to further promote their effectiveness. This study is to examine the effectiveness SDTM in assisting adult smokers in Hong Kong to quit.

Detailed Description

A randomized controlled trial (RCT) will be conducted. One-hundred adult smokers aged 25 or above will be recruited from smoking hotspots in Hong Kong. Participants in the intervention group will be contacted by our trained research assistant to receive a telephone counselling session at baseline. Participants can choose to receive their own smoking cessation treatment options from our menu. Control group participants will only receive a self-help quitting leaflet

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria
  • have smoking in the previous 30 days.
  • be above 25 years old
  • able to speak Cantonese and read Chinese
Exclusion Criteria
  • who are receiving current smoking cessation services
  • report psychological disorders
  • at risk of suicide

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mixed and MatchMixed and match InterventionParticipants can choose to receive their own smoking cessation treatment options from our menu.
ControlControlParticipants will receive a self-help quitting leaflet
Primary Outcome Measures
NameTimeMethod
Self-efficacy at 6-month follow-upAt 6-month follow-up

Participants will be asked about their self-efficacy in quitting. The score ranges from 0 to 10. Higher scores represent a higher self-efficacy.

Self-reported abstinence at 6-month follow-upAt 6-month follow-up

participants will be asked about their self-reported abstinence in the past 7 and 30 days

Biochemically validated abstinenceAt 6 months follow-up

validate the self-reported abstinence if the level of carbon monoxide in expired air was less than 4 parts per million and saliva cotinine level was less than100 ng/mL in parallel tests

Secondary Outcome Measures
NameTimeMethod
Missing data at 6-month follow-upAt 6-month follow-up

calculated as the percentage of missing values in the dataset

Screening rateat day 1

calculated as the number of smokers screened at smoking hotspots by the RA divided by number of smokers available

Randomization rateat day 1

calculated by dividing the number of smokers who are randomized into intervention and control groups by those who provide consent.

Retention rate at 3-month follow-upAt 3-month follow-up

calculated by dividing the number of smokers who remain in the study by those who are randomized

Adherence to intervention protocol at 6-month follow-upAt 6-month follow-up

calculated by dividing the number of smokers who follow and practice the chosen treatment options by those who are randomized

Attendance rateImmediately after the training workshop

calculated by dividing the number of smokers who complete the intervention by those who are randomized.

Retention rate at 1-month follow-upAt 1-month follow-up

calculated by dividing the number of smokers who remain in the study by those who are randomized

Complete rate at 1-week follow-upAt 1-week follow-up

calculated by dividing the number of smokers who returned questionnaires by the number of questionnaires distributed

Missing data at 3-month follow-upAt 3-month follow-up

calculated as the percentage of missing values in the dataset

Self-efficacy at 1-week follow-upat 1-week follow-up

Participants will be asked about their self-efficacy in quitting. The score ranges from 0 to 10. Higher scores represent a higher self-efficacy.

Retention rate at 1-week follow-upAt 1-week follow-up

calculated by dividing the number of smokers who remain in the study by those who are randomized

Complete rate at 1-month follow-upAt 1-month follow-up

calculated by dividing the number of smokers who returned questionnaires by the number of questionnaires distributed

Eligibility rateat day 1

calculated by dividing the number of smokers who are eligible by the number who are screened.

Retention rate at 6-month follow-upAt 6-month follow-up

calculated by dividing the number of smokers who remain in the study by those who are randomized

Adherence to intervention protocol at 1-week follow-upAt 1-week follow-up

calculated by dividing the number of smokers who follow and practice the chosen treatment options by those who are randomized

Adherence to intervention protocol at 1-month follow-upAt 1-month follow-up

calculated by dividing the number of smokers who follow and practice the chosen treatment options by those who are randomized

Adherence to intervention protocol at 3-month follow-upAt 3-month follow-up

calculated by dividing the number of smokers who follow and practice the chosen treatment options by those who are randomized

Adverse events at 3-month follow-upAt 3-month follow-up

Participants will report any unfavorable and unintended events

Self-reported abstinence at 1-week follow-upAt 1-week follow-up

Participants will be asked about their self-reported abstinence in the past 7 and 30 days

Self-reported abstinence at 3-month follow-upAt 3-month follow-up

participants will be asked about their self-reported abstinence in the past 7 and 30 days

Complete rate at 3-month follow-upAt 3-month follow-up

calculated by dividing the number of smokers who returned questionnaires by the number of questionnaires distributed

Complete rate at 6-month follow-upAt 6-month follow-up

calculated by dividing the number of smokers who returned questionnaires by the number of questionnaires distributed

Missing data at 1-month follow-upAt 1-month follow-up

calculated as the percentage of missing values in the dataset

Adverse events at 1-month follow-upAt 1-month follow-up

Participants will report any unfavorable and unintended events

Self-reported abstinence at 1-month follow-upAt 1-month follow-up

participants will be asked about their self-reported abstinence in the past 7 and 30 days

Missing data at 1-week follow-upAt 1-week follow-up

calculated as the percentage of missing values in the dataset

Adverse events at 1-week follow-upAt 1-week follow-up

Participants will report any unfavorable and unintended events

Self-efficacy at 1-month follow-upat 1-month follow-up

Participants will be asked about their self-efficacy in quitting. The score ranges from 0 to 10. Higher scores represent a higher self-efficacy.

Adverse events at 6-month follow-upAt 6-month follow-up

Participants will report any unfavorable and unintended events

Self-efficacy at 3-month follow-upat 3-month follow-up

Participants will be asked about their self-efficacy in quitting. The score ranges from 0 to 10. Higher scores represent a higher self-efficacy.

© Copyright 2025. All Rights Reserved by MedPath